Replies to post #406916 on Amarin Corp Plc (AMRN)

[dukesking]

We can only hope that MITIGATE results is what has recently silenced Nissen’s criticism of REDUCEIT and Vascepa. Maybe he’s one of the doctors that was allowed to review some of the data from MITIGATE.

[Whalatane]

Zip. In my experience with Kaiser ...they will only stop prescribing drug if a well respected study shows harm .
This is what happened with Niacin at least .
Study came out showing risk outweighed benefit ...still took a couple of months before they stopped prescribing it.
MITIGATE is controlled by Kaiser . They choose when and how to present results .
If the trial was controlled by a biotech / pharma Co like AMRN ...Co will normally release top line results if positive ..asap.... with details followed up in a publication ( NEJM or Lancet ) which might be embargoed until a conference.

Kiwi

[cloudera]

Just a contrarian view. If vascepa did not provide meaningful MITIGATE results plus if Amarin provided Vascepa to KP cheaper than Lovaza, KP would prescribe Vascepa as both drugs are ineffective against CVD. So, We cannot assume the results are somewhat positive.

My hope is that we get a positive result from MITIGATE.